Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Cash from Investing Activities (2023 - 2025)

Fractyl Health's Cash from Investing Activities history spans 3 years, with the latest figure at -$3000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 98.71% year-over-year to -$3000.0, compared with a TTM value of -$557000.0 through Dec 2025, up 68.44%, and an annual FY2025 reading of -$557000.0, up 68.44% over the prior year.
  • Cash from Investing Activities for Q4 2025 was -$3000.0 at Fractyl Health, up from -$8000.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was -$3000.0 in Q4 2025, with the low at -$1.1 million in Q1 2024.
  • Average Cash from Investing Activities over 3 years is -$223416.7, with a median of -$142000.0 recorded in 2023.
  • Year-over-year, Cash from Investing Activities tumbled 5195.0% in 2024 and then soared 98.71% in 2025.
  • Tracing GUTS's Cash from Investing Activities over 3 years: stood at -$136000.0 in 2023, then crashed by 71.32% to -$233000.0 in 2024, then soared by 98.71% to -$3000.0 in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Cash from Investing Activities are -$3000.0 (Q4 2025), -$8000.0 (Q3 2025), and -$98000.0 (Q2 2025).